NCT05316428View on ClinicalTrials.gov

A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

April 2, 2022

Study Completion Date

April 6, 2022

Conditions
AlcoholPhosphodiesterase InhibitorErectile Dysfunction
Interventions
DRUG

TPN171H tablet plus alcohol

10 mg TPN171H tablet QD plus 0.5 g/kg alcohol

OTHER

alcohol

0.5 g/kg alcohol

DRUG

TPN171H tablet

10 mg TPN171H tablet QD

Trial Locations (1)

Unknown

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
lead

Vigonvita Life Sciences

INDUSTRY